Methanol → HCID 178435508, 화합물

HRID 541354노트

반응식

HRID 541354 반응식
[NH2:1][C:2]1[O:6][C:5]([C:7]2[C:8]([CH:32]3[CH2:35][CH2:34][CH2:33]3)=[CH:9][C:10]([CH2:30][CH3:31])=[C:11]([CH:29]=2)[C:12]([N:14]2[CH2:19][CH2:18][C:17]([C:21]3[CH:28]=[CH:27][C:24]([C:25]#[N:26])=[CH:23][CH:22]=3)([F:20])[CH2:16][CH2:15]2)=[O:13])=[N:4][N:3]=1.[OH-].[K+].[CH3:38]O>>[CH:32]1([C:8]2[C:7]([C:5]3[NH:1][C:2]([O:6][CH3:38])=[N:3][N:4]=3)=[CH:29][C:11]([C:12]([N:14]3[CH2:15][CH2:16][C:17]([C:21]4[CH:22]=[CH:23][C:24]([C:25]#[N:26])=[CH:27][CH:28]=4)([F:20])[CH2:18][CH2:19]3)=[O:13])=[C:10]([CH2:30][CH3:31])[CH:9]=2)[CH2:35][CH2:34][CH2:33]1

참가 물질

4

반응물 3

HCID 887MethanolHCID 14797Potassium HydroxideHCID 682889534-(1-(5-(5-Amino-1,3,4-oxadiazol-2-yl)-4-cyclobutyl-2-ethylbenzoyl)-4-fluoropiperidin-4-yl)benzonitrile2회

생성물 1

HCID 178435508HCID 178435508, 화합물수율 10%

반응 조건

온도
70 °C

실험 절차

To a round-bottom flask, which was purged and maintained with a nitrogen atmosphere, was added a solution of 4-(1-(5-(5-amino-1,3,4-oxadiazol-2-yl)-4-cyclobutyl-2-ethylbenzoyl)-4-fluoropiperidin-4-yl)benzonitrile (compound 217.3, 200 mg, 0.420 mmol, 1.00 equiv) in methanol (20 mL). Potassium hydroxide (237 mg, 4.22 mmol, 10.0 equiv) was added to the reaction mixture. The resulting solution was stirred for 15 h at 70° C. After cooling to ambient temperature, the organic solvent was removed under reduced pressure. The residue was diluted with 30 mL of H2O, then extracted with 2×50 mL of ethyl acetate. The combined organic layers were washed with 2×50 mL of brine, dried over anhydrous sodium sulfate and concentrated in vacuo. The crude product (50 mg) was purified by Prep-HPLC with the following conditions (1#-Pre-HPLC-001(SHIMADZU)): Column, SunFire Prep C18, 19*150 mm 5 um; mobile phase, water with 0.05% TFA and CH3CN (49.0% CH3CN up to 63.0% in 8 min, up to 100.0% in 1 min, down to 49.0% in 1 min); Detector, Waters 2489 254&220 nm. The fractions containing pure compound were combined and lyophilized to yield 20 mg (10%) of the title compound as a white. m/z (ES+) 488 (M+H)+. 1H-NMR (300 MHz, CD3OD): δ 7.72 (d, 2H), 7.64-7.61 (m, 2H), 7.39-7.25 (m, 2H), 4.85-4.78 (m, 1H), 4.00-3.93 (m, 4H), 3.54-3.49 (m, 2H), 3.28-3.22 (m, 1H), 2.80-2.65 (m, 2H), 2.26-1.84 (m, 10H), 1.45-1.27 (m, 3H).

후처리

  1. customTo a round-bottom flask, which was purged
  2. temperaturemaintained with a nitrogen atmosphere
  3. temperatureAfter cooling to ambient temperature
  4. customthe organic solvent was removed under reduced pressure
  5. additionThe residue was diluted with 30 mL of H2O
  6. extractionextracted with 2×50 mL of ethyl acetate
  7. washThe combined organic layers were washed with 2×50 mL of brine
  8. dry with materialdried over anhydrous sodium sulfate
  9. concentrationconcentrated in vacuo
  10. customThe crude product (50 mg) was purified by Prep-HPLC with the following conditions (1#-Pre-HPLC-001(SHIMADZU))
  11. waitmobile phase, water with 0.05% TFA and CH3CN (49.0% CH3CN up to 63.0% in 8 min
  12. waitup to 100.0% in 1 min
  13. waitdown to 49.0% in 1 min)
  14. additionThe fractions containing pure compound

출처 및 근거

ORD 기록
ord-24fcb53449a74714882e3262427fd1ab
출처 데이터셋
uspto-grants-2014_10
특허 번호
US08871790B2

반응 노트

불러오는 중…